Balyasny Asset Management L.P. 13D and 13G filings for Mersana Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 06:01 am Sale | 2024-09-30 | 13G | Mersana Therapeutics, Inc. MRSN | Balyasny Asset Management L.P. | 535,819 0.440% | -9,162,328 (-94.48%) | Filing |
| 2024-02-14 07:22 am Purchase | 2023-12-31 | 13G | Mersana Therapeutics, Inc. MRSN | Balyasny Asset Management L.P. | 9,698,147 8.040% | 9,698,147 (New Position) | Filing |